eXoZymes Inc (EXOZ)

eXoZymes Inc. recorded six insider trading transactions over the past ninety days, resulting in a net negative value of approximately $13,021. While the Chief Executive Officer initiated multiple purchases, a significant sale by the Chief Commercial Officer outweighed these acquisitions. The stock price has declined 37.7% recently, following the company's latest November 2026 earnings report.
Ticker: EXOZ Exchange: NAS


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for eXoZymes Inc. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Perriman Damien Alan Chief Commercial Officer Officer
Transaction date
Sale
Price
442.34
Quantity 54,629 -27.3%
Value US$350,077
3.9
Heltzen Michael Chief Executive Officer Officer
Transaction date
Purchase
Price
261.32
Quantity 3,202 +10.7%
Value US$3,986,365
3.9
Heltzen Michael Chief Executive Officer Officer
Transaction date
Purchase
Price
498.89
Quantity 4,882 -29.7%
Value US$415,913
3.9
Heltzen Michael Chief Executive Officer Officer
Transaction date
Purchase
Price
7.58
Quantity 4 +0.0%
Value US$30
3.9
Heltzen Michael Chief Executive Officer Officer
Transaction date
Purchase
Price
7.50
Quantity 100 +0.7%
Value US$750
3.9
Heltzen Michael Chief Executive Officer Officer
Transaction date
Purchase
Price
7.52
Quantity 250 +1.8%
Value US$1,880
3.4
Korman Tyler Paz Chief Scientific Officer Officer
Transaction date
Sale
Price
10.53
Quantity 750 -0.1%
Value US$7,894
3.4
Korman Tyler Paz Chief Scientific Officer Officer
Transaction date
Sale
Price
10.04
Quantity 750 -0.1%
Value US$7,530
3.9
Heltzen Michael Chief Executive Officer Officer
Transaction date
Purchase
Price
10.22
Quantity 1,040 +10.8%
Value US$10,629
3.9
Heltzen Michael Chief Executive Officer Officer
Transaction date
Purchase
Price
10.78
Quantity 1,767 +83.9%
Value US$19,048
3.9
Heltzen Michael Chief Executive Officer Officer
Transaction date
Purchase
Price
10.72
Quantity 121 +6.1%
Value US$1,297
3.9
Heltzen Michael Chief Executive Officer Officer
Transaction date
Purchase
Price
11.10
Quantity 1,984 New position
Value US$22,022
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-10-26 2026-10-12 S Sale

Chief Commercial Officer

Officer
54,629 -27.3%
442.34
US$350,077
54,629 -27.3% 442.34 US$350,077
2026-09-02 2026-08-26 B Purchase

Chief Executive Officer

Officer
3,202 +10.7%
261.32
US$3,986,365
3,202 +10.7% 261.32 US$3,986,365
2026-09-02 2026-08-26 B Purchase

Chief Executive Officer

Officer
4,882 -29.7%
498.89
US$415,913
4,882 -29.7% 498.89 US$415,913
2026-09-02 2026-08-26 B Purchase

Chief Executive Officer

Officer
4 +0.0%
7.58
US$30
4 +0.0% 7.58 US$30
2026-09-02 2026-08-25 B Purchase

Chief Executive Officer

Officer
100 +0.7%
7.50
US$750
100 +0.7% 7.50 US$750
2026-09-02 2026-08-25 B Purchase

Chief Executive Officer

Officer
250 +1.8%
7.52
US$1,880
250 +1.8% 7.52 US$1,880
2026-04-10 2026-04-09 S Sale

Chief Scientific Officer

Officer
750 -0.1%
10.53
US$7,894
750 -0.1% 10.53 US$7,894
2026-04-10 2026-04-08 S Sale

Chief Scientific Officer

Officer
750 -0.1%
10.04
US$7,530
750 -0.1% 10.04 US$7,530
2025-07-02 2025-07-02 B Purchase

Chief Executive Officer

Officer
1,040 +10.8%
10.22
US$10,629
1,040 +10.8% 10.22 US$10,629
2025-01-21 2025-01-17 B Purchase

Chief Executive Officer

Officer
1,767 +83.9%
10.78
US$19,048
1,767 +83.9% 10.78 US$19,048
2025-01-21 2025-01-16 B Purchase

Chief Executive Officer

Officer
121 +6.1%
10.72
US$1,297
121 +6.1% 10.72 US$1,297
2024-11-19 2024-11-15 B Purchase

Chief Executive Officer

Officer
1,984 New position
11.10
US$22,022
1,984 New position 11.10 US$22,022